Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
3.145.75.238

A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing

By Su, Qinglin; Ganesh, Sudarshan Moreno, Mariana Bommireddy, Yasasvi; Gonzalez, Marcial; Reklaitis, Gintaras V.; Nagy, Zoltan K.

Published on

Abstract

The Quality-by-Design (QbD) guidance issued by the US Food and Drug Administration (FDA) has catalyzed the modernization of pharmaceutical manufacturing practices including the adoption of continuous manufacturing. Active process control was highlighted recently as a means to improve the QbD implementation. This advance has since been evolving into the concept of Quality-by-Control (QbC). In this study, the concept of QbC is discussed, including a definition of QbC, a review of the recent developments towards the QbC, and a perspective on the challenges of QbC implementation in continuous manufacturing. The QbC concept is demonstrated using a rotary tablet press, integrated into a pilot scale continuous direct compaction process. The results conclusively showed that active process control, based on product and process knowledge and advanced model-based techniques, including data reconciliation, model predictive control (MPC), and risk analysis, is indispensable to comprehensive QbC implementation, and ensures robustness and efficiency.

Journal

Computers & Chemical Engineering. Volume 125,, 2019, 216-231

DOI

10.1016/j.compchemeng.2019.03.001

Type of publication

Peer-reviewed journal

Affiliations

  • Davidson School of Chemical Engineering, Purdue University

Article Classification

Research Article

Classification Areas

  • Control
  • Regulatory

Tags